LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Novasenta

Similar companies to Novasenta

Novasenta Tech Stack

Media & News

Novasenta's Email Address Formats

Novasenta uses at least 1 format(s):
Novasenta Email FormatsExamplePercentage
First.Last@novasenta.comJohn.Doe@novasenta.com
100%

Frequently Asked Questions

Where is Novasenta's headquarters located?

Minus sign iconPlus sign icon
Novasenta's main headquarters is located at 350 Technology Dr Suite 501 Pittsburgh, Pennsylvania 15219 US. The company has employees across 1 continents, including North America.

How much revenue does Novasenta generate?

Minus sign iconPlus sign icon
As of October 2024, Novasenta's annual revenue reached $1.8M.

What is Novasenta's SIC code NAICS code?

Minus sign iconPlus sign icon
Novasenta's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Novasenta have currently?

Minus sign iconPlus sign icon
As of October 2024, Novasenta has approximately 18 employees across 1 continents, including North America. Key team members include Executive Assistant To The Chief Executive Officer Office Manager: D. K.Acting Chief Medical Officer: T. L.Founder: D. V.. Explore Novasenta's employee directory with LeadIQ.

What industry does Novasenta belong to?

Minus sign iconPlus sign icon
Novasenta operates in the Biotechnology Research industry.

What is Novasenta's email format?

Minus sign iconPlus sign icon
Novasenta's email format typically follows the pattern of . Find more Novasenta email formats with LeadIQ.

How much funding has Novasenta raised to date?

Minus sign iconPlus sign icon
As of October 2024, Novasenta has raised $15M in funding. The last funding round occurred on Feb 05, 2024 for $15M.

When was Novasenta founded?

Minus sign iconPlus sign icon
Novasenta was founded in 2019.
Novasenta

Novasenta

Biotechnology ResearchPennsylvania, United States11-50 Employees

Novasenta discovers novel therapeutic targets to develop innovative and effective treatments with the goal of transforming the lives of patients with cancer. 

We use systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable targets, exploiting the critical interplay of disease, immune response, and metabolism. Single-cell level analysis of high-quality, human tumor samples combined with the advanced data mining abilities of our research and computational biology teams accelerate the path from discovery to patient. Our goal is to identify novel targets to generate effective therapies for a range of cancers. 

Section iconCompany Overview

Headquarters
350 Technology Dr Suite 501 Pittsburgh, Pennsylvania 15219 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $15M

    Novasenta has raised a total of $15M of funding over 2 rounds. Their latest funding round was raised on Feb 05, 2024 in the amount of $15M.

  • $10M

    Novasenta's revenue is in the range of $10M

Section iconFunding & Financials

  • $15M

    Novasenta has raised a total of $15M of funding over 2 rounds. Their latest funding round was raised on Feb 05, 2024 in the amount of $15M.

  • $10M

    Novasenta's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.